Status:

UNKNOWN

Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes

Lead Sponsor:

Universidad de Guanajuato

Collaborating Sponsors:

Hospital Regional de Alta Especialidad del Bajio

Conditions:

Prediabetic State

Insulin Resistance

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

Type 2 diabetes is a worldwide epidemic disease, and preventive strategies are needed to face this health problem. The goal of this trial is to evaluate the effect of empagliflozin + linagliptin + met...

Detailed Description

The main goal of this clinical trial is to compare the effect of two different treatments during 12 months: 1. Lifestyle modification program + metformin 850 mg twice daily 2. Lifestyle modification ...

Eligibility Criteria

Inclusion

  • Patients with prediabetes, defined for the existence impaired glucose tolerance (glucose between 140 and 199 mg/dL at the 2 hours of the Oral Tolerance Glucose Test (OGTT) with impaired fasting glucose (fasting glucose between 100 and 125 mg/dL)
  • Patients who accept to participate in the study and sign the informed consent letter.

Exclusion

  • Patients with diagnosed Type 2 Diabetes previously or detected during the OGTT
  • Patients in actual treatment or during the last 3 months with metformin, pioglitazone or another antidiabetic drug, including insulin
  • Serum creatinine \> 1.6 mg/dL
  • Hypertriglyceridemia very high (\>500 mg/dL)
  • Pregnant women
  • Altered arterial hypertension (Systolic \>180 mmHg or Diastolic \>105 mmHg)
  • Excessive alcohol intake, acute or chronic
  • Medications or medical conditions that affect glucose homeostasis (thiazides, beta blockers, glucocorticoids for systemic use, weight-reducing drugs or anorexigenics, Cushing´s syndrome, thyrotoxicosis

Key Trial Info

Start Date :

September 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2020

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT04131582

Start Date

September 1 2019

End Date

December 30 2020

Last Update

October 21 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universidad de Guanajuato

León, Guanajuato, Mexico, 37670